ELDN (ELDN) Stock Price & Analysis
ELDN (ELDN) rose 3.07% to USD 3.02 as of September 8, 2026 at 13:16 UTC, according to Nexqual real-time market data.
ELDN last closed at USD 3.02; the session ranged USD 2.93–3.06 on volume of 1,197,883 shares. Market capitalization is —, with a 52-week range of USD 1.35–4.6 (NCM). Source: Nexqual, September 8, 2026 at 13:16 UTC.
Key Statistics (as of September 8, 2026 at 13:16 UTC)
| Price | USD 3.02 |
|---|---|
| Change | ▲ 3.07% (up) |
| Previous Close | USD 3.02 |
| Open | USD 3.02 |
| Day Range | USD 2.93 – 3.06 |
| 52-Week Range | USD 1.35 – 4.6 |
| Volume | 1,197,883 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (ELDN)
Nexqual's technical model rates ELDN "SELL" based on 2 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 13:16 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 29.41 (oversold) |
| vs SMA50 | Below (USD 3.61) |
| MACD | -0.18 (negative) |
From ELDN's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ABOS | Acumen Pharmaceuticals, Inc. | USD 3.18 | ▲ 2.58% |
| TARA | Protara Therapeutics, Inc. | USD 3.94 | ▲ 0% |
| LRMR | Larimar Therapeutics, Inc. | USD 3.83 | ▼ 1.03% |
| RZLT | Rezolute, Inc. | USD 4.58 | ▲ 0.44% |
| ALGS | Aligos Therapeutics, Inc. | USD 6.21 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 13:16 UTC. This page is informational and not investment advice.